The cases of two patients who bear a superficial resemblance to Huntington's chorea are described. The reasons against the condition being hereditary are explained and the importance of a diagnosis of nonhereditarv chronic adult chorea is stressed.
Summary
The cases of two patients who bear a superficial resemblance to Huntington's chorea are described. The reasons against the condition being hereditary are explained and the importance of a diagnosis of nonhereditarv chronic adult chorea is stressed.
I am indebted to those medical colleagues and the district registrars of births and deaths who made the ancestry of these patients so clear. REFERENCES Bell, J. (1934 In Huntington's chorea the main features requiring treatment are dementia and a psychosis, in addition to the chronic choreic movements from which the title derives.
In ancient times some patients were said to have had their heads opened to allow the escape of devils, and Vessie (1932) has described how many were burned as witches in Connecticut. When these remedies fell into disfavour it was not, however, because any more effective therapy became available.
With the first description of the condition, Dr. George Huntington was able to draw on experience of many years with the affected families, but he recognized that " treatment seems to be of no avail." In more recent times Russell Brain (1951) states that no form of treatment is known to arrest progress of the dementia or to control the involuntary movements, and Kinnier Wilson (1954) Tomlinson (1947) that an extract of Bulgarian belladonna was helpful has been denied by De Meyer and Dyken (1954) . Goldman (1952) conducted a trial with procainamide after the chance observation that a patient relaxed well after an injection for a dental extraction. De Meyer and Dyken (1954) did confirm a subjective response to this but showed no improvement in any of their patients' chorea. Reserpine was advocated by Chandler (1955) and Lazarte et al. (1955) . Nielsen and Butt (1955) reported from Los Angeles a poor result with the use of dimercaprol.
Over the years some of the patients described in our local survey have been tried on these drugs but rather spasmodically and by many different observers (see Table) . In tabulating these results for convenience it should be noted that dosage has varied and is not mentioned, the stage of the patients' disease has varied, many patients had died before the newer drugs were available, and the observations are so lacking in standardization that any slight improvement has been noted. Where no sign appears there is no record of that drug being given. The patients' numbers refer to the classification in the preceding articles.
The variables already mentioned make impossible the assessment of these results in concrete terms. In order to achieve a standard environment for the trials the patients were all treated at home, as previous experience had shown that hospitalization could help or worsen the chorea over short periods. Fortunately none of the patients suffered any serious infections which might have affected their condition adversely.
Though the patients were specially examined before, during, and after the trial, the regular visits were paid by their own practitioners, men with local knowledge and much experience of this disorder.
In view of the small number of patients concerned it was not practicable to follow the double-blind technique. Instead the patients formed their own controls during the second phase of the trial, which proved a useful way to even out the individual variations.
The cases were treated with thiopropazate for a period of three months, receiving one 10-mg. tablet thrice daily after meals. The drug was then discontinued, and, for a second period of three months, tablets which were inert but of a similar appearance were given as controL The original drug was then administered once more, but in a totally different form-namely, as a pink sugar-coated tablet instead of the original white tablet. All other drugs affecting the nervous system were stopped during this time. Checks of blood, urine, and blood-pressure were carried out periodically along with frequent assessment of the patients' physical ability, mental state, and the condition of the house.
Results
There were many drawbacks to devising a yardstick or a formula by which the patients' progress could be gauged collectively. It is therefore thought more suitable to review each case individually, but the details are abbreviated considerably. though he could otherwise dress himself. Definite improvement was noted by the eleventh day after starting thiopropazate. He could concentrate, was sleeping better, was less depressed, and was more reliable on his legs. He gradually began to do jobs in the house as the chorea of his arms lessened, and was eventually able to help the fishermen mend their nets, a highly specialized operation which would have been quite impossible before. With discontinuance of the drug he relapsed and in about five days the chorea was as marked as it had been before. When thiopropazate was restarted the improvement in his ability to work reappeared.
A, II 5.-A woman aged 58 had been shown to have a non-hereditary chronic adult chorea. She was not greatly disabled, but there was a marked chorea of her limbs as well as jerking of her head which slowed her in her household duties. She realized that she was easily excited, and this tended to make her physical state worse. After taking thiopropazate for four days she felt much calmer, and this gave her increased confidence, which helped in her chorea and her efficiency in the house increased. The change to inert tablets caused the return of her nervousness and chorea, resulting in neglect of the house again. She became more easily tired and found that she could not cope so well. On returning to thiopropazate the picture of improvement reappeared and she remained as well as in the early part of the trial.
Progress
To cover the interval since this trial began a brief progress note is appropriate.
One patient has died. N, III27 was elderly and fragile. He continued to get up, dress, and go for walks, but when his daughter left home his elderly wife could not manage the care of her house and the patient, in spite of such remarkable improvement. For care MEDIBJSHOJNAL and attention he was therefore admitted to hospital as a case of senile dementia and died of bronchopneumonia.
One patient has now discontinued the tablets. The mild temporary upset suffered by C, IV 13 upset her relatives and the trial could not be continued. She is being maintained on combinations of other phenothiazine drugs and is a little better than before.
The drug was continued in the remaining cases. R, III 2 has in recent months aged greatly owing to advancing years, bronchitis, and cerebral deterioration. It is undoubtedly due to thiopropazate that he remains so well.
K, IV 32 progresses well, doing small jobs which previously his chorea would have prevented. His mood varies and when irritable there is some increase in the involuntary movement.
A, II 5 and K, V 2 continue to show a benefit from the treatment. A greater degree of excitement is required to upset them, but when it does occur they both show some increase in chorea and loss of physical ability.
Reslts Five patients with Huntington's chorea and one with a non-hereditary form of chorea have each been benefited by treatment with thiopropazate. The earliest response, on the second to third day, has been a calming of excitement and prevention of outbursts.
An improvement in the chorea has been noted in each case, usually after about two to three weeks. Using as a guide the ability to perform simple tasks, each patient has improved to a degree varying with the incapacity at the outset. The most affected pair showed the most spectacular improvement. N, III 27 was able to manage a boiled egg; R, III 2 was able to mend nets. These are both great accomplishments for a choreic. C, IV 13 and K, IV 32 improved from being able to care for themselves to being capable of useful tasks round the house. K, V 2 and A, II 5, the mildest cases, had the least improvement to demonstrate. Both did, however, show more efficiency in their houses and their chorea was less obvious.
Psychiatric disturbance was also helped. Aggressiveness and manic-depressive tendencies have been greatly lessened. Some improvement in the intellectual powers was demonstrated in three male patients who resumed an interest in daily papers.
The dementia alone has not responded to this form of treatment. In R, III 2 this has now become obvious, whereas it was only suspect before. N, III 27 became more active than was safe for his degenerate brain and he had to be admitted to hospital for his own safety.
No evidence of haemopoietic, cardiovascular, renal, or hepatic dysfunction was evident in any of these patients. Pseudo-Parkinsonism appeared in C, IV 13 as a temporary phenomenon.
Discussion
The symptoms of Huntington's chorea may be grouped under the headings of chorea, psychosis, and dementia. A great step forward can be claimed in the introduction of thiopropazate, which has now been shown to influence the first two symptoms, though the action on the other symptom is less evident. Barbiturate sedation was previously the only effective treatment, but its results were extremely limited. Early phenothiazine drugs did help a little, but were erratic in their action.
The initial improvement was in the composure of the patients, and could have been anticipated from the known " tranquillizing " effect which was found with drugs of the promazine type.
About three weeks after the administration of thiopropazate the chorea was first noticed to be lessening. This time lag suggests that two distinct mechanisms are having effect in these patients. Some improvement has been demonstrated in these cases in the past by the calming effect of barbiturates, but the great improvement in physical condition quoted above outweighs anything previously shown, and it is therefore claimed that thiopropazate has a more specific action than that of a general sedative.
Some understanding of the need to relate the dose of thiopropazate to body weight may be gained from this trial: 30 mg. a day was given to all the patients. This can be assumed to be an effective dose and was well tolerated by the five patients of average weight and size. C, IV 13, on the other hand, was of very small stature and showed the reactions of overdosage such as were described by Heaton-Ward et al. (1959) for this drug. It is perhaps a pointer to one of the sites of action of thiopropazate as well as illustrating the balance of power amongst the basal ganglia that the frank chorea previously exhibited by this patient became quieter; then, as the optimal dose was exceeded, she showed the features of pseudo-Parkinsonism.
Summary
Previous forms of drug therapy are briefly reviewed from old records and the help afforded by phenobarbitone in particular is mentioned.
A small series of Huntington's chorea cases has been treated with thiopropazate in the environment of home care, and this lasted nine months.
Thiopropazate is a safe and an effective substance for the treatment of the involuntary movement and the psychosis of Huntington's chorea. Dementia is less liable to amelioration, but at least institutional care can in most cases be delayed or avoided. The results compare very favourably with those of previous forms of treatment, including other derivatives of phenothiazine.
Apart from a temporary disturbance in one patient due to relative overdosage no toxic effects were noted. 
